S2M
vs
OMX Stockholm 30
Over the past 12 months, S2M has underperformed OMX Stockholm 30, delivering a return of -90% compared to the OMX Stockholm 30's 9% growth.
Stocks Performance
S2M vs OMX Stockholm 30
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
JP |
Hoya Corp
TSE:7741
|
||
CH |
Alcon AG
SIX:ALC
|
||
DK |
Coloplast A/S
CSE:COLO B
|
||
US |
Align Technology Inc
NASDAQ:ALGN
|
||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
|
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
||
US |
Lantheus Holdings Inc
NASDAQ:LNTH
|
||
CA |
Bausch + Lomb Corp
NYSE:BLCO
|
||
UK |
ConvaTec Group PLC
LSE:CTEC
|
||
US |
Merit Medical Systems Inc
NASDAQ:MMSI
|
Performance Gap
S2M vs OMX Stockholm 30
JP |
Hoya Corp
TSE:7741
|
||
CH |
Alcon AG
SIX:ALC
|
||
DK |
Coloplast A/S
CSE:COLO B
|
||
US |
Align Technology Inc
NASDAQ:ALGN
|
||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
|
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
||
US |
Lantheus Holdings Inc
NASDAQ:LNTH
|
||
CA |
Bausch + Lomb Corp
NYSE:BLCO
|
||
UK |
ConvaTec Group PLC
LSE:CTEC
|
||
US |
Merit Medical Systems Inc
NASDAQ:MMSI
|
Performance By Year
S2M vs OMX Stockholm 30
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
JP |
Hoya Corp
TSE:7741
|
||
CH |
Alcon AG
SIX:ALC
|
||
DK |
Coloplast A/S
CSE:COLO B
|
||
US |
Align Technology Inc
NASDAQ:ALGN
|
||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
|
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
||
US |
Lantheus Holdings Inc
NASDAQ:LNTH
|
||
CA |
Bausch + Lomb Corp
NYSE:BLCO
|
||
UK |
ConvaTec Group PLC
LSE:CTEC
|
||
US |
Merit Medical Systems Inc
NASDAQ:MMSI
|
Competitors Performance
S2Medical AB (publ) vs Peers
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
HR |
C
|
CROBEX
INDX:CRBEX
|
|
SA |
T
|
Tadawul All Share
INDX:TASI
|
|
TH |
S
|
SET Index
INDX:SET
|
|
ID |
J
|
Jakarta Composite Index
INDX:JKSE
|
|
GR |
A
|
Athens General Composite
INDX:ATG
|
|
BR |
B
|
BOVESPA
INDX:BVSP
|
|
AR |
S
|
S&P Merval
INDX:MERV
|
|
MX |
M
|
Mexico S&P/BMV IPC
INDX:MXX
|
|
CZ |
P
|
PX Prague Stock Index
INDX:PX
|
|
RU |
M
|
MOEX Russia
INDX:IMOEX
|
S2Medical AB (publ)
Glance View
S2Medical AB engages in research and development in biotechnology. The company is headquartered in Linkoping, Ostergotland. The company went IPO on 2018-11-28. The firm focuses on developing products for healing burns and chronic wounds, from debridement and granulation to reepithelialization. The firm's product portfolio includes INSTAQRETT, a sterile single-use mechanical debridement tool, the Epiprotect product line based on its collagen-mimicking Eiratex material, which includes EPIPROTECT Safestop, a blood-stilling membrane dressing, EPIPROTECT 2117, a synthetic substitute to allografts and xenografts, EPIPROTECT ULCER, dressing for treating ulcers, as well as INSTABIND bandages and Instagraft, a single-use medical device designed to treat chronic wounds with microtransplants from the patient's own skin without creating any new wounds. The firm is also the official distributor of Silverlon antimicrobial dressings for Nordic countries. In addition, it operates the S2Clinic, a wound healing center in Sweden.